These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 381153)

  • 21. [Beta cell function in insulin-treated diabetes mellitus determined by C-peptide measurement].
    Faber OK
    Ugeskr Laeger; 1980 Jan; 142(4):215-21. PubMed ID: 6986696
    [No Abstract]   [Full Text] [Related]  

  • 22. [Secretory potentialities of beta cells at early stages of diabetes mellitus].
    Ruiatkina LA; Dikker VE; Galenok VA
    Med Radiol (Mosk); 1986 Feb; 31(2):81-4. PubMed ID: 3512952
    [No Abstract]   [Full Text] [Related]  

  • 23. Basal and glucagon-stimulated plasma C-peptide concentrations in healthy dogs, dogs with diabetes mellitus, and dogs with hyperadrenocorticism.
    Montgomery TM; Nelson RW; Feldman EC; Robertson K; Polonsky KS
    J Vet Intern Med; 1996; 10(3):116-22. PubMed ID: 8743209
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [HLA antigens, hormonal profile and insulin antibodies in insulin-dependent diabetes mellitus with retinopathy].
    Vasiukova EA; Guliaeva ES; Kantsel'son LA; Kniazev IuA; Mikhaĭlova NA
    Klin Med (Mosk); 1981 Nov; 59(11):42-6. PubMed ID: 7033655
    [No Abstract]   [Full Text] [Related]  

  • 25. Glucagon-like peptide 1 increases mass but not frequency or orderliness of pulsatile insulin secretion.
    Pørksen N; Grøfte B; Nyholm B; Holst JJ; Pincus SM; Veldhuis JD; Schmitz O; Butler PC
    Diabetes; 1998 Jan; 47(1):45-9. PubMed ID: 9421373
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Insulin secretion and hepatic extraction in juvenile non-insulin-dependent diabetes].
    Carta G; Viviani GL; Borgoglio MG; Noberasco G; Del Nero E; Adezati L
    Minerva Endocrinol; 1989; 14(3):177-83. PubMed ID: 2695816
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Twenty-four-hour insulin secretion rates, circulating concentrations of fuel substrates and gut incretin hormones in healthy offspring of Type II (non-insulin-dependent) diabetic parents: evidence of several aberrations.
    Nyholm B; Walker M; Gravholt CH; Shearing PA; Sturis J; Alberti KG; Holst JJ; Schmitz O
    Diabetologia; 1999 Nov; 42(11):1314-23. PubMed ID: 10550415
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Pathogenetic relationship between insulin resistance, insulin secretion and impaired glucose tolerance in patients with obesity].
    Abdurakhmanova AM; Kosovskiĭ MI; Rakhimov NR; Guliamov TD
    Probl Endokrinol (Mosk); 1988; 34(2):21-4. PubMed ID: 3293029
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Physiological and pharmacological stimulation of pancreatic islet hormone secretion in type I diabetic pancreas allograft recipients.
    Osei K; Henry ML; O'Dorisio TM; Tesi RJ; Sommer BG; Ferguson RM
    Diabetes; 1990 Oct; 39(10):1235-42. PubMed ID: 2210076
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insulin sensitivity and beta-cell secretion in thalassaemia major with secondary haemochromatosis: assessment by oral glucose tolerance test.
    Cario H; Holl RW; Debatin KM; Kohne E
    Eur J Pediatr; 2003 Mar; 162(3):139-146. PubMed ID: 12655415
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impaired beta-cell function, incretin effect, and glucagon suppression in patients with type 1 diabetes who have normal fasting glucose.
    Greenbaum CJ; Prigeon RL; D'Alessio DA
    Diabetes; 2002 Apr; 51(4):951-7. PubMed ID: 11916912
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The interrelationship between insulin secretion and action in type 2 diabetes mellitus with different degrees of obesity: evidence supporting central obesity.
    Duman BS; Turkoglu C; Gunay D; Cagatay P; Demiroglu C; Buyukdevrim AS
    Diabetes Nutr Metab; 2003 Aug; 16(4):243-50. PubMed ID: 14768774
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glucagon-like peptide-1 stimulates insulin secretion by a Ca2+-independent mechanism in Zucker diabetic fatty rat islets of Langerhans.
    Sreenan SK; Mittal AA; Dralyuk F; Pugh WL; Polonsky KS; Roe MW
    Metabolism; 2000 Dec; 49(12):1579-87. PubMed ID: 11145120
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of beta-cell function impairment in first-degree relatives of type 2 diabetic subjects: modeling analysis of 24-h triple-meal tests.
    Mari A; Gastaldelli A; Natali A; Ostergard T; Schmitz O; Ferrannini E
    Am J Physiol Endocrinol Metab; 2005 Mar; 288(3):E541-6. PubMed ID: 15522997
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Independent measures of insulin secretion and insulin sensitivity during the same test: the glucagon-insulin tolerance test.
    Dorkhan M; Tripathy D; Malm G; Asgharian H; Tuomi T; Groop L
    J Intern Med; 2008 Jul; 264(1):62-71. PubMed ID: 18298489
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Abnormal glucose counterregulation in insulin-dependent diabetes mellitus. Interaction of anti-insulin antibodies and impaired glucagon and epinephrine secretion.
    Bolli G; de Feo P; Compagnucci P; Cartechini MG; Angeletti G; Santeusanio F; Brunetti P; Gerich JE
    Diabetes; 1983 Feb; 32(2):134-41. PubMed ID: 6337896
    [TBL] [Abstract][Full Text] [Related]  

  • 37. C-peptide secretion and insulin antibodies as determinants of stability in diabetes mellitus.
    Yue DK; Baxter RC; Turtle JR
    Metabolism; 1978 Jan; 27(1):35-44. PubMed ID: 619224
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Insulin secretion--assay method and its significance].
    Emoto M; Sato Y; Oka Y
    Nihon Rinsho; 1997 Apr; 55 Suppl 2():418-22. PubMed ID: 9172560
    [No Abstract]   [Full Text] [Related]  

  • 39. Glucagon-like peptide-1(7-36)-amide confers glucose sensitivity to previously glucose-incompetent beta-cells in diabetic rats: in vivo and in vitro studies.
    Dachicourt N; Serradas P; Bailbé D; Kergoat M; Doaré L; Portha B
    J Endocrinol; 1997 Nov; 155(2):369-76. PubMed ID: 9415071
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Insulin secretion defects in liver cirrhosis can be reversed by glucagon-like peptide-1.
    Siegel EG; Seidenstücker A; Gallwitz B; Schmitz F; Reinecke-Lüthge A; Klöppel G; Fölsch UR; Schmidt WE
    J Endocrinol; 2000 Jan; 164(1):13-9. PubMed ID: 10607933
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.